# Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’

> **Open Intelligence Dossier** · First detected: 2026-08-09 19:07 UTC · Category: Health

## Executive Summary
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’" is generating significant coverage in the Health category, with 10 articles from 10 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Standard-Examiner, Oncodaily, Medscape and OncLive. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Standard-Examiner | Intermountain Hospitals in Ogden, Layton to be among first to administer new pancreatic cancer drug | [Source Link](https://news.google.com/rss/articles/CBMi2AFBVV95cUxQZmlpVzNLSkk5YmZMMFFxQTNoNFpsTXk2V3JYTUhsdVhCZjJNYWRXOVFSQ0RMd1ltRDkwWmpxWlJubHptLS1rc3I5X2hMRjlCRmMzaGZwYmVMODExM1cxdEZNSHZEYWI5UnNLS2NCX0RYeXJNZXdwME50cXFUdVlPQ2VrWkRwWHluSHB4a3VUWml6aER2X3doX3lCeFIxZERWaW9LNzRUYWphclFOZXRfSERPMlVzQm5mTGVnYXRnd3hDVFY4OG9aOWRoUkZ0UG56UXNudzNTNDg?oc=5) |
| Oncodaily | Arturo Loaiza-Bonilla: Daraxonrasib Brings New Hope to Pancreatic Cancer Patients | [Source Link](https://news.google.com/rss/articles/CBMiaEFVX3lxTE9Da2cxc3d0THoxRUQxazQ5X1BZOXRkUmwzWkJPUnV3QkRIYnJLOTdsYURrdF9CV0xSSGdLVWFySFVBNDdlaGJUTDZpR240QU1XbUlaRHhqeUlQVGlXdl9NeGxlOGhBcU5y?oc=5) |
| Medscape | Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib | [Source Link](https://news.google.com/rss/articles/CBMiqAFBVV95cUxQTHpBcjlfaU84ZHpGZkczeGgyUHptTjFEc2hoYnlsMXRpeEY4enppdXRaY19DckZPVjNlRHlDZG5QTmd1UUotR192MVp3bDlHbDNrQVdTdkstZ3gxMERJZ3dxbENjMzlGVVBIM2VjZ0lUV0JMQVVONHRvbGRMZVhzb2h2R3IwRXZGN29WUFFYQndVdzNnNkNlaWpqRm50bzBYWng1cjRPc0U?oc=5) |
| OncLive | Cracking the KRAS Code: Daraxonrasib's Practice-Changing Data in Pancreatic Cancer and Beyond | [Source Link](https://news.google.com/rss/articles/CBMivgFBVV95cUxPSnNmLW1ndVRqZjZmVTlqQmh0UDdBSXNaT1dWZlVjSjdlLWZRN0IySHFtMnprYnA1VmhQUHN1aDJ3TlNfTjFCTExNM3Z6QmFIOUVsOFFKQ25rdzlLUUdxdkhBT2UzVzVLNlhwVXUyeElEMmlpVG9jeFNqMXpmX3lNZlpzcXdYcXZyNUZHQmc4b1FnNGdFT0R0RDAybFRlSjhMLVBxTjdGM1ZpaFpwSTZmb292cHRSci01MnY4NlpB?oc=5) |
| Stanford Medicine | Stanford expands access to revolutionary pancreatic cancer drug | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxPcnFPQzY4YlgxSndiM3BlNHRCeXdxcVRRNjhfVHJSbUZBbXRRSHlHeGg0bS1UMTF0OTdQU3VnTnZMVUliMXZ3RXpMdGkxZkJLMTd5OXVzSEM0Y2hkTldmdTVfdzdwWFhMbV9GRU5heXZLb3lsZWhIZUlfVG5YZ0xfNmNPdC1QMWZ4MFcxcEJ3R0pjSGozUm1FR1dfck1YendVZmJCZzJZUHJSa2I3aHdlbw?oc=5) |
| News-Medical | New drug delivers promising survival gains in pancreatic cancer | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxOaEJscGw5RVlqcHFlLVk1ZlpYTWNwRkM2NENwSUJsejNhUW9xMnJ6YkZGNVNPcnJVR2hOQlBnZEl1M3hMeXhhdnFpRzNJQ0gzSEVid0FSa21VSEtHNzRfVlYwNWNCb1B5MW43ME5jMHdFZ2pqUlp6M2pTT3Fzblh0anprMmZVcWVId0FqbF9VX1VkdWUzcEJfdUdWUlFZbnUzaTJGb28ydmFpZ1J1cV9XeQ?oc=5) |
| The Clinical Trial Vanguard | FDA Accepts daraxonrasib Application for RAS-Mutant Pancreatic Cancer | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxQcHF5VlJQX2RCVUI0djFsbG5GS2NZRXJXQlZwY3R0OE90cHNwSDZTQzFMbVlxTG83eHVYZUdjUk1wdDA3SGVKUzBhZ24wYzJmdUpTN25jbXhDRmozaU5HdTg4eThhY2xxcXAxdndHZGRvWUNFMC0yRkk3MkNJemFual8xMnZ6RTVZT2lWUTFQR3ZncTVVX1QzSW5hQldwTWJ4bUZEdDlKZUM0S2ZGV0VGQmowbw?oc=5) |
| University of Utah Health | Breakthrough Drug Brings Hope to Utah Grandfather with Pancreatic Cancer | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxPcG85YlVwajZPMy1zMlFOQzNRZVAyaTBKRE5tRXlQODFNTHlRRWMxZnFmal85UEg1a1hrWnZqaDQ0XzBBS0t1ODRrMThlZUcxWWxqdDJPY2RNRmd6cldxbEMzdXNiaFRkOUZ1Zm1DMERKbjZOUWJmeEV5ZDBXS1N0ajdPUEtVcFhTY1NDRHk1eFRKNHhjeVhBN0tn?oc=5) |
| NH Business Review | Letter to the editor: Good news for patients — and a reminder of what’s at stake | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxNQVFRb2xXS29KMHJoZ2llR0J6ODNOOFhScjZPaDBjZUU0TjZSMDluZ2FNam5XcU5Wci1pX0h6aG0xbldSMkhENHdnTkhqNTd2T3lEcWZMcVhBM2Y2OG1ZVERkeXE3UG5RaUQ3U2stbGlBMDFDcmhSTEtwS0F2N3JhUkJuSjEwd2M0Z0VkMWdyR2NEMUVkaTBLMmFEZ3ZFM2M?oc=5) |
| Chicago Tribune | Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxQTW9TVFZIVGJ0TVpNSWh5WXpVSXBVNEYycVdMX25KR1pXak9UNjFDQzc4TWs3QzY0UjIwaUVqWGNhTTNMOElGOWQ5bkdPeGJ0UlJTRmNyNmJSTkFVdXR6dk5KVlAtTWJSd2c4V0hpRnV2dURRZW1aZTNsSUpscDhRQUVBMXM?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-08-09/patients-in-illinois-starting-to-receive-experimental-pancreatic-cancer-drug*